Cellectis (CLLS) Operating Income Growth (5y) (2020 - 2026)
Cellectis (CLLS) Operating Income Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | Cellectis | 288.51 Mn | 102.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.80% |
| Dec 31, 2025 | 15.02% |
| Sep 30, 2025 | 17.86% |
| Jun 30, 2025 | 21.92% |
| Mar 31, 2025 | -24.44% |
| Dec 31, 2024 | 22.62% |
| Sep 30, 2024 | 16.58% |
| Jun 30, 2024 | 13.30% |
| Mar 31, 2024 | 2.00% |
| Dec 31, 2023 | -0.21% |
| Sep 30, 2023 | 6.49% |
| Jun 30, 2023 | -1.71% |
| Mar 31, 2023 | 1.21% |
| Dec 31, 2022 | 27.24% |
| Sep 30, 2022 | -1.25% |
| Jun 30, 2022 | -6.59% |
| Mar 31, 2022 | -8.16% |
| Dec 31, 2021 | -3.86% |
| Sep 30, 2021 | -26.85% |
| Jun 30, 2021 | -27.06% |